Pediatric rheumatology

Connective tissue nevus misdiagnosed as juvenile localized scleroderma

Pediatr Rheumatol Online JPublished Retrospective case series

Authors' conclusion

CTN can be misdiagnosed as JLS and therefore aggressively treated with prolonged and inappropriate immunosuppression.

Study context

Population
Children referred over the last two decades for juvenile localized scleroderma (JLS) who received a final diagnosis of connective tissue nevi (CTN)15 certain, 2 suspected JLS
Participants
17 children
Outcome
Characteristics of CTN misdiagnosed as JLS
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Mean age at onset
4.6 years
Lesions mainly at lower limbs
14 (82.4%)
Lesions at upper limbs
3 (17.6%)
Laboratory inflammatory changes or positive autoantibodies
0
Non-familial collagenoma on biopsy
11 (64.7%)
Mixed CTN on biopsy
4 (23.5%)
Familial CTN on biopsy
2 (11.8%)
Mean age at final diagnosis
9.5 years
Mean diagnostic delay
4.8 years (range 1-15 years)
Musculoskeletal MRI abnormal (muscle perifascial enhancement), of 16 scanned
2
Thermography normal
all patients
On systemic treatment at first evaluation
11 (64.7%)
Systemic treatment: MTX / corticosteroids / biologics
11 / 7 / 2
On topical corticosteroids
3 (17.6%)
Untreated
3

Observational data: associations, not effects.

Original publication

Connective tissue nevus misdiagnosed as juvenile localized scleroderma. Pediatr Rheumatol Online J. Published 17 October 2023. doi:10.1186/s12969-023-00913-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.